Hypothyroidism

Order serum TSH as the principal diagnostic test when primary thyroid failure is suspected. An elevated TSH with low free T4 indicates overt primary hypothyroidism; elevated TSH with free T4 in the laboratory reference interval indicates subclinical hypothyroidism. acpjournals+2acpjournalsHypothyroidismacpjournalsSubclinical Hypothyroidism Is an Independent Risk Factor ...CDC3. HEALTH EFFECTS

Obtain free T4 whenever TSH is abnormal and whenever pituitary or hypothalamic disease is clinically plausible. Low free T4 accompanied by a low or non-elevated TSH is discordant with primary gland failure and suggests central TSH deficiency; monitor replacement with free T4 rather than TSH in secondary or tertiary hypothyroidism. acpjournals+1acpjournalsHypothyroidismPubMedLevothyroxine Treatment and the Risk of Cardiac Arrhythmias

Interpret a mildly elevated TSH against age and persistence. TSH shifts upward with age in people without demonstrable thyroid disease, and subclinical hypothyroidism becomes more prevalent in later life. In the major older-adult replacement trial, eligibility required TSH 4.6-19.9 mU/L, normal free T4, and confirmation on at least two measurements separated by at least 3 months; this approach helps avoid treating a transient abnormality. clinicaltrials+1clinicaltrialsStudy Details | NCT01660126 | Thyroid Hormone Replacement for Subclinical Hypothyroidism | ClinicalTrials.govcdn clinicaltrialsThe Thyroid Axis in Older Individuals with Persistent Subclinical

For adults with newly diagnosed hypothyroidism and no complicating cardiac disease, an initial levothyroxine dose of 1.6 mcg/kg/day is a typical full-replacement strategy. In patients older than 65 years or those with pre-existing heart disease, begin at 25 mcg/day and increase by 12.5-25 mcg every 4-6 weeks rather than immediately using a full weight-based dose. PubMedPubMedLevothyroxine Treatment and the Risk of Cardiac Arrhythmias

Use TSH to titrate primary hypothyroidism, obtaining the first post-initiation or post-adjustment measurement after approximately 6-8 weeks. After the correct dose is achieved, repeat testing at 4-6 months and then every 12 months. Recheck after a formulation or brand change and after starting or stopping medications that affect thyroid hormone levels. PubMed+2PubMedLevothyroxine Treatment and the Risk of Cardiac ArrhythmiasPubMedLevothyroxine - StatPearls - NCBI Bookshelf - NIHPubMedHypothyroidism - StatPearls - NCBI Bookshelf

A persistently abnormal TSH while prescribed levothyroxine should prompt a structured medication review before repeated empiric dose escalation. Verify the product and formulation, interval adherence, food and medication interactions, and new therapies that alter thyroid hormone levels; fluctuating TSH or an unusually high dose requirement warrants this review. PubMedPubMedHypothyroidism - StatPearls - NCBI Bookshelf

Use free T4 rather than TSH to monitor central hypothyroidism. In hospitalized patients unable to take oral thyroid replacement, IV levothyroxine may be used at approximately 50%-75% of the oral dose; reserve IV treatment for strict inability to use the enteral route or myxedema coma. PubMed+1PubMedLevothyroxine Treatment and the Risk of Cardiac ArrhythmiasPubMedHypothyroidism - StatPearls - NCBI Bookshelf

In older adults, persistent subclinical hypothyroidism should not automatically trigger levothyroxine. A practical threshold is to withhold treatment unless TSH increases to at least 10 mIU/L or overt primary hypothyroidism emerges, defined by elevated TSH with low free T4. PubMedPubMedHypothyroidism in Older Adults - Endotext - NCBI Bookshelf

When treatment is chosen for an older patient, use a start-low, go-slow approach: levothyroxine 25-50 mcg daily with increases every 6-8 weeks. The cited age-specific targets are TSH below 6 mIU/L for adults younger than 80 years and below 7 mIU/L for adults 80 years or older, while avoiding angina or other evidence of excessive replacement. PubMedPubMedHypothyroidism in Older Adults - Endotext - NCBI Bookshelf

This conservative strategy is especially relevant because TSH increases progressively with age in otherwise euthyroid people and because subclinical hypothyroidism is common after age 65. Confirm elevated TSH with normal free T4 on repeat testing before labeling persistent disease or committing a patient to long-term replacement. clinicaltrials+1clinicaltrialsStudy Details | NCT01660126 | Thyroid Hormone Replacement for Subclinical Hypothyroidism | ClinicalTrials.govcdn clinicaltrialsThe Thyroid Axis in Older Individuals with Persistent Subclinical

Suspect myxedema coma in a patient with hypothyroidism and altered mental status, particularly with hypothermia, bradycardia, hyponatremia, heart failure, or hypopnea. Common precipitants include surgery, infection, cold exposure, and sedative administration. The diagnosis is clinical; treatment should begin when suspicion is high rather than awaiting thyroid results. PubMed+1PubMedMyxedema Coma - StatPearls - NCBI BookshelfPubMedPerioperative Management of Thyroid Dysfunction - PMC

Draw random cortisol, TSH, free T4, and free T3 if this does not delay therapy. Give IV hydrocortisone before thyroid hormone because thyroid replacement can increase cortisol metabolism and unmask adrenal insufficiency; a cited regimen is hydrocortisone 100 mg IV initially, totaling 200-400 mg/day, with de-escalation guided by cortisol results and resolution of hypotension. PubMed+1PubMedGuidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement - PMCPubMedMyxedema Coma - StatPearls - NCBI Bookshelf

Administer IV levothyroxine with a 200-400 mcg loading dose, using lower doses in smaller or older patients and those with coronary disease or arrhythmia. Follow with replacement at 1.6 mcg/kg/day, reduced to 75% while administered intravenously; transition to enteral therapy after clinical improvement. Measure TSH, free T4, and free T3 every 24-48 hours for dose adjustment during acute treatment. PubMed+1PubMedGuidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement - PMCPubMedMyxedema Coma - StatPearls - NCBI Bookshelf

Admit to intensive care for cardiorespiratory support and active treatment of the precipitating illness. Reported mortality associated with myxedema coma has been as high as 80%, making prompt thyroid hormone replacement, glucocorticoid coverage, and physiologic support more important than diagnostic perfection. PubMed+1PubMedMyxedema Coma - StatPearls - NCBI BookshelfPubMedPerioperative Management of Thyroid Dysfunction - PMC

Postpone nonemergent surgery in severe hypothyroidism, including myxedema coma, altered mentation, pericardial effusion, heart failure, or very low thyroxine below 1 mcg/dL. If surgery is emergent, rapidly replace thyroid hormone with IV levothyroxine 200-500 mcg loading followed by 50-100 mcg IV daily; consider IV liothyronine if myxedema coma is suspected and provide glucocorticoids when adrenal insufficiency is a concern. PubMedPubMedPerioperative Management of Thyroid Dysfunction - PMC

During immune checkpoint inhibitor therapy, hypothyroidism may follow a thyrotoxic phase. The biochemical definition remains elevated TSH with normal T4/T3 in subclinical disease or low T4/T3 in overt disease. In atezolizumab protocols, asymptomatic hypothyroidism was managed by continuing immunotherapy, initiating thyroid replacement, and checking TSH weekly; symptomatic hypothyroidism prompted temporary withholding until symptoms were controlled and thyroid function was improving. cdn clinicaltrials+2cdn clinicaltrialsOfficialTitle: APhaseIII,Open-Label,Multicenter,Three-Arm, ...cdn clinicaltrialsprotocolASCOEndocrine Dysfunction From Immune Checkpoint Inhibitors